Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect

被引：48
|
作者：
Stader, Felix [1 ,2 ,3 ]
Khoo, Saye [4 ]
Stoeckle, Marcel [1 ,2 ,3 ]
Back, David [4 ]
Hirsch, Hans H. [1 ,2 ,5 ]
Battegay, Manuel [1 ,2 ,3 ]
Marzolini, Catia [1 ,2 ,3 ,4 ]
机构：
[1] Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Dept Med, Basel, Switzerland
[2] Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Dept Clin Res, Basel, Switzerland
[3] Univ Basel, Basel, Switzerland
[4] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England
[5] Univ Basel, Dept Biomed, Transplantat & Clin Virol, Basel, Switzerland
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2020年 / 75卷 / 10期
关键词：
ENZYMES; CYP1A2; CYP3A4;
D O I：
10.1093/jac/dkaa253
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
下载
收藏
页码：3084 / 3086
页数：3
相关论文
共 50 条
  • [21] A Trial of Lopinavir-Ritonavir in Covid-19 Reply
    Cao, Bin
    Zhang, Dingyu
    Wang, Chen
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (21):
  • [22] BET 1: LOPINAVIR-RITONAVIR AND COVID-19
    Dolan, Daniel
    Ingham, Jack
    Baombe, Janos
    EMERGENCY MEDICINE JOURNAL, 2020, 37 (07) : 450 - +
  • [23] No Benefit for Lopinavir-Ritonavir in Severe COVID-19
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (20): : 1999 - 1999
  • [24] Lopinavir / ritonavir for COVID-19: A living systematic review
    Verdugo-Paiva, Francisca
    Izcovich, Ariel
    Ragusa, Martin
    Rada, Gabriel
    MEDWAVE, 2020, 20 (06):
  • [25] Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)
    Schoergenhofer, Christian
    Jilma, Bernd
    Stimpfl, Thomas
    Karolyi, Mario
    Zoufaly, Alexander
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (08) : 670 - +
  • [26] High rate of major drug-drug interactions of lopinavir-ritonavir for COVID-19 treatment
    Macias, Juan
    Pinilla, Ana
    Lao-Dominguez, Francisco A.
    Corma, Anais
    Contreras-Macias, Enrique
    Gonzalez-Serna, Alejandro
    Gutierrez-Pizarraya, Antonio
    Fernandez-Fuertes, Marta
    Morillo-Verdugo, Ramon
    Trigo, Marta
    Real, Luis M.
    Pineda, Juan A.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [27] Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
    Zhu, Zhen
    Lu, Zhaohui
    Xu, Tianmin
    Chen, Cong
    Yang, Gang
    Zha, Tao
    Lu, Jianchun
    Xue, Yuan
    JOURNAL OF INFECTION, 2020, 81 (01) : E21 - E23
  • [28] Maculopapular rash in COVID-19 patient treated with lopinavir/ritonavir
    Mazan, Paula
    Lesiak, Aleksandra
    Skibinska, Malgorzata
    Kamerys, Juliusz
    Czajkowski, Rafal
    Owczarek, Witold
    Narbutt, Joanna
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2020, 37 (03): : 435 - 437
  • [29] Evaluation of retinotoxicity of COVID-19 treatment: Hydroxychloroquine and lopinavir/ritonavir
    Burgos-Blasco, Barbara
    Guemes-Villahoz, Noemi
    Vidal-Villegas, Beatriz
    Donate-Lopez, Juan
    Garcia-Feijoo, Julian
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) : 644 - 646
  • [30] The comparison of favipiravir and lopinavir/ritonavir combination in COVID-19 treatment
    Cinarka, Halit
    Gunluoglu, Gulsah
    Cortuk, Mustafa
    Yurt, Sibel
    Kiyik, Murat
    Kosar, Filiz
    Tanriverdi, Elif
    Arslan, Melih Akay
    Baydili, Kursad Nuri
    Koc, Aysu Sinem
    Altin, Sedat
    Cetinkaya, Erdogan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (04) : 1624 - 1630
12345